KRAS, NRAS and BRAF Mutation Profiling in a Series of 90 Metastasic Colorectal Cancer Spanish Patients - An Estimation of Cost Savings

被引：0
|
作者：
Rodon, Natalia
Roman Llado, Ruth
Verdu, Montse
del Mar Montes, Maria
Garcia-Pelaez, Beatriz
Diaz, Olga
Lacasa, Carmen
Puig, Xavier
机构：
[1] BIOPAT Biopatol Mol Grp Assistencia, Barcelona, Spain
[2] Histopat Lab, Barcelona, Spain
[3] Hosp Barcelona SCIAS, Barcelona, Spain
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
741
引用
收藏
页码：187A / 187A
页数：1
相关论文
共 50 条
  • [31] Correlation between KRAS, NRAS and BRAF mutations and tumor localizations in patients with primary and metastatic colorectal cancer
    Bozyk, Aleksandra
    Krawczyk, Pawel
    Reszka, Katarzyna
    Krukowska, Kinga
    Kolak, Agnieszka
    Mandziuk, Slawomir
    Wojas-Krawczyk, Kamila
    Ramlau, Rodryg
    Milanowski, Janusz
    ARCHIVES OF MEDICAL SCIENCE, 2022, 18 (05) : 1221 - 1230
  • [32] Patterns of KRAS, NRAS and BRAF testing among patients with metastatic colorectal cancer in the EU5.
    Lowe, Kimberly
    Niu, Xin
    Kafatos, George
    Kelsh, Michael Anthony
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [33] Exploring the Relationship Between KRAS, NRAS, and BRAF Mutations and Clinical Characteristics in Iranian Colorectal Cancer Patients
    Mosaferi, Zahra
    Pirestani, Majid
    Arefian, Ehsan
    Gojani, Goli
    Kavousinasab, Nastaran
    Karimi, Parto
    Deilami, Azam
    Abrehdari-Tafreshi, Zahra
    JOURNAL OF GASTROINTESTINAL CANCER, 2024, 55 (03) : 1134 - 1143
  • [34] Clinicopathological Features and Prognostic Value of KRAS/NRAS/BRAF Mutations in Colorectal Cancer Patients of Central China
    Xiao-na Chang
    Fu-mei Shang
    Hong-yu Jiang
    Chen Chen
    Zhe-yan Zhao
    Sheng-he Deng
    Jun Fan
    Xiao-chuan Dong
    Ming Yang
    Yan Li
    Kai-lin Cai
    Li Liu
    Hong-li Liu
    Xiu Nie
    Current Medical Science, 2021, 41 : 118 - 126
  • [35] KRAS, NRAS, and BRAF mutation prevalence, clinicopathological association, and their application in a predictive model in Mexican patients with metastatic colorectal cancer: A retrospective cohort study
    Sanchez-Ibarra, Hector Eduardo
    Jiang, Xianli
    Gallegos-Gonzalez, Elena Yareli
    Cavazos-Gonzalez, Adriana Carolina
    Chen, Yenho
    Morcos, Faruck
    Barrera-Saldana, Hugo Alberto
    PLOS ONE, 2020, 15 (07):
  • [36] Mutation profiling of KRAS, BRAF, and PIK3CA genes in colorectal cancer tissue.
    McKeown, S.
    Doherty, J. E.
    Beaney, M. P.
    Latten, M. J.
    Murray, H. A.
    Crockard, M. A.
    Lamont, J. V.
    FitzGerald, S. P.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [37] Impact of KRAS mutation on patterns of metastasis in a series of colorectal cancer patients
    Domenech Vinolas, M.
    Santos, C.
    Martin Francisco, J. Perez
    Varela, M.
    Merche, M.
    Grasselli, J.
    Teule, A.
    Soler, G.
    Mulet Margalef, N.
    Bergamino Sirven, M.
    Ortega Franco, A.
    Sanjuan, X.
    Salazar, R.
    ANNALS OF ONCOLOGY, 2016, 27 : 47 - 47
  • [38] Evaluation of KRAS, NRAS and BRAF mutations detection in plasma using an automated system for patients with metastatic colorectal cancer
    Franczak, Claire
    Witz, Andrea
    Geoffroy, Karen
    Demange, Jessica
    Rouyer, Marie
    Husson, Marie
    Massard, Vincent
    Gavoille, Celine
    Lambert, Aurelien
    Gilson, Pauline
    Gambier, Nicolas
    Scala-Bertola, Julien
    Merlin, Jean-Louis
    Harle, Alexandre
    PLOS ONE, 2020, 15 (01):
  • [39] Mutation Pattern of KRas and BRAF Oncogenes and Their Comparison With Clinicopathological Features in Patients With Colorectal Cancer
    Katalinic, D.
    Plestina, S.
    Rako, I.
    Caban, D.
    Sertic, J.
    Jakic-Razumovic, J.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S403 - S403
  • [40] Treatment and survival of patients with de novo metastatic colorectal cancer (mCRC) rested for KRAS, NRAS or BRAF mutations
    Booker, Ben D.
    Markt, Sarah C.
    Schumacher, Fredrick R.
    Rose, Johnie
    Cooper, Greg S.
    Selfridge, J. Eva
    Koroukian, Siran M.
    CANCER RESEARCH, 2022, 82 (12)
12345